Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?

SIMPLE SUMMARY: Cell surface proteases (so-called ectoproteases) are associated with cancer, and their targeting may confer valuable options for the improvement of cancer treatment outcome. Over the past 20 years, the permanent development of a multitude of inhibitors against several ectoproteases (...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhulst, Emile, Garnier, Delphine, De Meester, Ingrid, Bauvois, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833564/
https://www.ncbi.nlm.nih.gov/pubmed/35158891
http://dx.doi.org/10.3390/cancers14030624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833564/
https://www.ncbi.nlm.nih.gov/pubmed/35158891
http://dx.doi.org/10.3390/cancers14030624

Ejemplares similares